Over the last years, NK cells have gained significant attention in the field of cancer immunotherapy and many efforts are emerging for developing and engineering NK cell-based cancer immunotherapy. Obtaining a large quantity of NK cells requires a democratized cell isolation solution for both pre-clinical and clinical applications. The new MARS Bar system enables a new generation of large scale, magnetic CD56+ cell isolation technology for separation of Apheresis, Leukopaks, Whole Blood or Bone Marrow cell products.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
We divide cookies into necessary cookies and third-party cookies that relate to functionality, technical issues and the collection of statistical and marketing data. No consent to third-party cookies allows you to continue using the website.
If you are looking for more information, we invite you to read our privacy policy.